OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Classical and non-classical psychedelic drugs induce common network changes in human cortex
Rui Dai, Tony E. Larkin, Zirui Huang, et al.
NeuroImage (2023) Vol. 273, pp. 120097-120097
Open Access | Times Cited: 35
Rui Dai, Tony E. Larkin, Zirui Huang, et al.
NeuroImage (2023) Vol. 273, pp. 120097-120097
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Psilocybin desynchronizes the human brain
Joshua S. Siegel, S. V. Subramanian, Demetrius Perry, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 131-138
Open Access | Times Cited: 65
Joshua S. Siegel, S. V. Subramanian, Demetrius Perry, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 131-138
Open Access | Times Cited: 65
Anesthesia and the neurobiology of consciousness
George A. Mashour
Neuron (2024) Vol. 112, Iss. 10, pp. 1553-1567
Closed Access | Times Cited: 20
George A. Mashour
Neuron (2024) Vol. 112, Iss. 10, pp. 1553-1567
Closed Access | Times Cited: 20
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 30
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 30
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 23
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 23
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 15
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 15
Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey
Nicolas G. Glynos, Jacob S. Aday, Daniel J. Kruger, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Nicolas G. Glynos, Jacob S. Aday, Daniel J. Kruger, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Unravelling consciousness and brain function through the lens of time, space, and information
Andrea I. Luppi, Fernando Rosas, Pedro A. M. Mediano, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 7, pp. 551-568
Open Access | Times Cited: 5
Andrea I. Luppi, Fernando Rosas, Pedro A. M. Mediano, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 7, pp. 551-568
Open Access | Times Cited: 5
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Blerida Banushi, Vince Polito
Biology (2023) Vol. 12, Iss. 11, pp. 1380-1380
Open Access | Times Cited: 13
Blerida Banushi, Vince Polito
Biology (2023) Vol. 12, Iss. 11, pp. 1380-1380
Open Access | Times Cited: 13
Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience
S. Parker Singleton, Christopher Timmermann, Andrea I. Luppi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11
S. Parker Singleton, Christopher Timmermann, Andrea I. Luppi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11
Consciousness and the Dying Brain
George A. Mashour, UnCheol Lee, Dinesh Pal, et al.
Anesthesiology (2024) Vol. 140, Iss. 6, pp. 1221-1231
Open Access | Times Cited: 4
George A. Mashour, UnCheol Lee, Dinesh Pal, et al.
Anesthesiology (2024) Vol. 140, Iss. 6, pp. 1221-1231
Open Access | Times Cited: 4
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
The ketamine chameleon: history, pharmacology, and the contested value of experience
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Connectome harmonic decomposition tracks the presence of disconnected consciousness during ketamine-induced unresponsiveness
Milan Van Maldegem, Jakub Vohryzek, Selen Atasoy, et al.
British Journal of Anaesthesia (2025)
Closed Access
Milan Van Maldegem, Jakub Vohryzek, Selen Atasoy, et al.
British Journal of Anaesthesia (2025)
Closed Access
Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review
Viktoriia Kurkova, Olga Winkler, Andrew J. Greenshaw, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111333-111333
Closed Access
Viktoriia Kurkova, Olga Winkler, Andrew J. Greenshaw, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111333-111333
Closed Access
Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience
S. Parker Singleton, Christopher Timmermann, Andrea I. Luppi, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
S. Parker Singleton, Christopher Timmermann, Andrea I. Luppi, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Ketamine-Occasioned Mystical Experience in Veterans with Treatment-Resistant Depression: A Retrospective Exploratory Analysis
Kush V. Bhatt, Jason Compton, Em Ellerman, et al.
Psychedelic Medicine (2025)
Closed Access
Kush V. Bhatt, Jason Compton, Em Ellerman, et al.
Psychedelic Medicine (2025)
Closed Access
The induction of dissociative states: A meta-analysis
Benjamin Brake, Lillian Wieder, Natasha Hughes, et al.
Biological Psychiatry Global Open Science (2025), pp. 100521-100521
Open Access
Benjamin Brake, Lillian Wieder, Natasha Hughes, et al.
Biological Psychiatry Global Open Science (2025), pp. 100521-100521
Open Access
Traumatic Psychedelic Experiences
Abigail E. Calder, Vincent J Diehl, Gregor Hasler
Current topics in behavioral neurosciences (2025)
Closed Access
Abigail E. Calder, Vincent J Diehl, Gregor Hasler
Current topics in behavioral neurosciences (2025)
Closed Access
Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments
Niloufar Pouyan, Jacob S. Aday, Steven E. Harte, et al.
Journal of Psychopharmacology (2025)
Closed Access
Niloufar Pouyan, Jacob S. Aday, Steven E. Harte, et al.
Journal of Psychopharmacology (2025)
Closed Access
LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics
Kenneth Shinozuka, Prejaas Tewarie, Andrea I. Luppi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Kenneth Shinozuka, Prejaas Tewarie, Andrea I. Luppi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Ketamine, the First Associative Anesthetic? Some Considerations on Classifying Psychedelics, Entactogens, and Dissociatives
Nicholas Denomme, Boris D. Heifets
American Journal of Psychiatry (2024) Vol. 181, Iss. 9, pp. 784-786
Closed Access | Times Cited: 3
Nicholas Denomme, Boris D. Heifets
American Journal of Psychiatry (2024) Vol. 181, Iss. 9, pp. 784-786
Closed Access | Times Cited: 3
Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology
Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The role of NMDARs in the anesthetic and antidepressant effects of ketamine
Liang Zhou, Jingjing Duan
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 7
Liang Zhou, Jingjing Duan
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 7
Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents
Roger S. McIntyre
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 10, pp. 885-889
Open Access | Times Cited: 6
Roger S. McIntyre
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 10, pp. 885-889
Open Access | Times Cited: 6
The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness
Frankie A. Colosimo, Philip Borsellino, Reese I. Krider, et al.
Psychoactives (2024) Vol. 3, Iss. 1, pp. 93-122
Open Access | Times Cited: 2
Frankie A. Colosimo, Philip Borsellino, Reese I. Krider, et al.
Psychoactives (2024) Vol. 3, Iss. 1, pp. 93-122
Open Access | Times Cited: 2
